Clinical Trial

Keloid Pathogenesis And Fibroblast Activation Study

Study acronym: KPS
Recruiting
View on ClinicalTrials.gov →
Summary
Keloids are benign fibroproliferative skin disorders characterized by excessive fibroblast activation and extracellular matrix deposition. The molecular mechanisms underlying keloid formation remain incompletely understood. This prospective observational study aims to investigate the biological characteristics of keloid tissue by comparing surgically resected keloid specimens with adjacent normal skin obtained from the same patients. Histological and molecular analyses, including histopathology, polymerase chain reaction (PCR), Western blotting, and related laboratory assays, will be performed to identify signaling pathways and key regulatory factors associated with fibroblast activation. The findings may improve the understanding of keloid pathogenesis and identify potential therapeutic targets for future treatment.
Trial Details
NCT Number NCT07682636
Lead Sponsor The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions Keloids, Fibroblast
Enrollment 20 participants
Start Date 2025-05-10
Primary Completion 2028-05-10 (estimated)
Study Completion 2028-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-06